The Hematology Track is ideal for fellows with a strong interest in an academic career in benign and/or malignant hematology. After completing the first year of single-board training in Hematology, fellows can either choose to:
- Enter directly into 2 years of mentored academic research training or
- Extend their clinical training by an additional 6 months to receive dual certification in Medical Oncology, followed by 18 months of research training
During the first year, Hematology Track fellows will rotate through the following clinical services:
Benign Hematology Inpatient Service
This unique inpatient hematology ward and consult experience run by the Division of Hematology provides fellows with intensive training to help them master inpatient management of benign hematologic diseases such as coagulation disorders, thrombotic thrombocytopenic purpura (TTP)/hemolytic uremic syndrome (HUS), hemophilia, bone marrow failure, paroxysmal nocturnal hemoglobinuria (PNH), and sickle cell disease.
This inpatient acute leukemia service exposes fellows to standard and trial chemotherapeutic regimens for the treatment of newly diagnosed or relapsed acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and aggressive myelodysplastic syndrome (MDS). In addition, fellows will learn the essentials of bone marrow biopsy and intrathecal chemotherapy techniques.
Myeloma, Transplant & Lymphoma (MTL) Service
This bone marrow transplant (BMT) ward provides fellows with training on a wide spectrum of BMT techniques such as autologous, allogeneic, matched-unrelated, haploidentical, and T cell depleted. Indications for BMT on this ward range from malignant diseases to genetic and autoimmune disorders.
Outpatient Malignant and Benign Hematology Service (Heme OPD)
This innovative outpatient experience provides fellows with the foundation to master outpatient care of patients with a wide variety of hematologic disorders. Fellows will work directly in faculty clinics to develop outpatient skills in non-malignant hematologic conditions such as hemophilia, clotting disorders, thrombotic microangiopathies, and cytopenias as well as patients with malignant conditions such as myeloid and lymphoid disorders.
In this rotation, fellows will learn the basics of bone marrow biopsy techniques and bone marrow biopsy interpretation. Fellows will become proficient in performing bone marrow biopsies and interpreting bone marrow aspirates, flow cytometry, and lymph node biopsies
This rotation through the Division of Transfusion Medicine exposes fellows to both theoretical concepts and practical experience in blood bank administration, donor procedures, donor testing, reference immunohematology, platelet serology, transfusion consultations, cytopheresis, bone marrow processing and therapeutic apheresis.
Sickle Cell Disease
This unique rotation designed to be an immersive experience in sickle cell disease care, including comprehensive outpatient care of sickle cell disease patients, acute pain management through the sickle cell infusion center, and newborn screening for sickle cell disease.
This rotation provides fellows with an introduction to palliative medicine, pain and symptom management, and end-of-life care. Fellows will have direct clinical experience in an inpatient hospice setting and palliative care clinics.
Hematologic Malignancies Continuity Clinic
This block-based continuity clinic allows fellows to work weekly with our world-renowned faculty to gain longitudinal outpatient experience in varied hematologic malignancies including myelodysplastic syndromes, myeloproliferative disorders, lymphomas and myelomas.
Adult Benign Hematology Continuity Clinic
This weekly clinic during the second year provides fellows with autonomy and targeted treatment in the outpatient management of non-malignant hematologic disorders such as thrombotic/bleeding disorders, immune cytopenias, and anemias. Fellows will have their own longitudinal patient panel with supervision by our world-class benign hematology faculty.